Tea Pemovska
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.
Journal: HemaSphere
Published: October 27, 2025
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery.
Journal: Cancer research
Published: February 27, 2025
Comparing functional and genomic-based precision medicine in blood cancer patients.
Journal: HemaSphere
Published: February 20, 2025
Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression.
Journal: Nature communications
Published: November 15, 2023
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Journal: The Journal of clinical investigation
Published: January 04, 2023
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine.
Journal: Blood cancer discovery
Published: November 24, 2021
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Journal: Cancer discovery
Published: April 26, 2021
Metabolic drug survey highlights cancer cell dependencies and vulnerabilities.
Journal: Nature communications
Published: October 13, 2020
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia.
Journal: Haematologica
Published: September 08, 2020
Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter.
Journal: Blood
Published: September 02, 2020
Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states.
Cell-surface SLC nucleoside transporters and purine levels modulate BRD4-dependent chromatin states.
Journal: Nature metabolism
Published: June 08, 2020
Last Updated: 09/26/2026